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Foreword 
 
The evaluation of research and doctoral training is being carried out in the years 2010–2012 and will end in 
2012. The steering group appointed by the Rector in January 2010 set the conditions for participating in 
the evaluation and prepared the Terms of Reference to present the evaluation procedure and criteria. The 
publications and other scientific activities included in the evaluation covered the years 2005–2010. 
The participating unit in the evaluation was defined as a Researcher Community (RC). To obtain a 
critical mass with university-level impact, the number of members was set to range from 20 to 120. The 
RCs were required to contain researchers in all stages of their research career, from doctoral students to 
principal investigators (PIs). All in all, 136 Researcher Communities participated in this voluntary 
evaluation, 5857 persons in total, of whom 1131 were principal investigators. PIs were allowed to 
participate in two communities in certain cases, and 72 of them used this opportunity and participated in 
two RCs. 
This evaluation enabled researchers to define RCs from the “bottom up” and across disciplines. The aim 
of the evaluation was not to assess individual performance but a community with shared aims and 
researcher-training activities. The RCs were able to choose among five different categories that 
characterised the status and main aims of their research. The steering group considered the process of 
applying to participate in the evaluation to be important, which lead to the establishment of these 
categories. In addition, providing a service for the RCs to enable them to benchmark their research at the 
global level was a main goal of the evaluation. 
The data for the evaluation consisted of the RCs’ answers to evaluation questions on supplied e-forms 
and a compilation extracted from the TUHAT – Research Information System (RIS) on 12 April 2011. The 
compilation covered scientific and other publications as well as certain areas of scientific activities. During 
the process, the RCs were asked to check the list of publications and other scientific activities and make 
corrections if needed. These TUHAT compilations are public and available on the evaluation project sites 
of each RC in the TUHAT-RIS. 
In addition to the e-form and TUHAT compilation, University of Leiden (CWTS) carried out bibliometric 
analyses from the articles included in the Web of Science (WoS). This was done on University and RC 
levels. In cases where the publication forums of the RC were clearly not represented by the WoS data, the 
Library of the University of Helsinki conducted a separate analysis of the publications. This was done for 
66 RCs representing the humanities and social sciences. 
The evaluation office also carried out an enquiry targeted to the supervisors and PhD candidates about 
the organisation of doctoral studies at the University of Helsinki. This and other documents describing the 
University and the Finnish higher education system were provided to the panellists. 
The panel feedback for each RC is unique and presented as an entity. The first collective evaluation 
reports available for the whole panel were prepared in July–August 2011. The reports were accessible to all 
panel members via the electronic evaluation platform in August. Scoring from 1 to 5 was used to 
complement written feedback in association with evaluation questions 1–4 (scientific focus and quality, 
doctoral training, societal impact, cooperation) and in addition to the category evaluating the fitness for 
participation in the evaluation. Panellists used the international level as a point of comparison in the 
evaluation. Scoring was not expected to go along with a preset deviation. 
Each of the draft reports were discussed and dealt with by the panel in meetings in Helsinki (from 11 
September to 13 September or from 18 September to 20 September 2011). In these meetings the panels 
also examined the deviations among the scores and finalised the draft reports together. 
The current RC-specific report deals shortly with the background of the evaluation and the terms of 
participation. The main evaluation feedback is provided in the evaluation report, organised according to 
the evaluation questions. The original material provided by the RCs for the panellists has been attached to 
these documents. 
 
 
 
 
 
 
 
 
 
On behalf of the evaluation steering group and office, I sincerely wish to thank you warmly for your 
participation in this evaluation. The effort you made in submitting the data to TUHAT-RIS is gratefully 
acknowledged by the University. We wish that you find this panel feedback useful in many ways. The 
bibliometric profiles may open a new view on your publication forums and provide a perspective for 
discussion on your choice of forums. We especially hope that this evaluation report will help you in setting 
the future goals of your research. 
 
Johanna Björkroth 
Vice-Rector 
Chair of the Steering Group of the Evaluation 
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Acronyms and abbreviations applied in the report 
 
External competitive funding 
AF – Academy of Finland 
TEKES - Finnish Funding Agency for Technology and Innovation  
EU - European Union 
ERC - European Research Council 
International and national foundations 
FP7/6 etc. /Framework Programmes/Funding of European Commission 
 
Evaluation marks 
Outstanding (5) 
Excellent  (4) 
Very Good  (3) 
Good  (2) 
Sufficient  (1) 
 
Abbreviations of Bibliometric Indicators 
P - Number of publications 
TCS – Total number of citations 
MCS - Number of citations per publication, excluding self-citations 
PNC - Percentage of uncited publications 
MNCS - Field-normalized number of citations per publication 
MNJS - Field-normalized average journal impact 
THCP10 - Field-normalized proportion highly cited publications (top 10%) 
INT_COV - Internal coverage, the average amount of references covered by the WoS 
WoS – Thomson Reuters Web of Science Databases 
 
Participation category 
Category 1. The research of the participating community represents the international cutting edge in its 
field. 
Category 2. The research of the participating community is of high quality, but the community in its 
present composition has yet to achieve strong international recognition or a clear break-through. 
Category 3. The research of the participating community is distinct from mainstream research, and the 
special features of the research tradition in the field must be considered in the evaluation. 
Category 4. The research of the participating community represents an innovative opening. 
Category 5. The research of the participating community has a highly significant societal impact. 
 
Research focus areas of the University of Helsinki 
Focus area 1: The basic structure, materials and natural resources of the physical world 
Focus area 2: The basic structure of life 
Focus area 3: The changing environment – clean water 
Focus area 4: The thinking and learning human being 
Focus area 5: Welfare and safety 
Focus area 6: Clinical research 
Focus area 7: Precise reasoning 
Focus area 8: Language and culture 
Focus area 9: Social justice 
Focus area 10: Globalisation and social change 
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1 Introduction to the Evaluation 
1.1 RC-specific evaluation reports 
The participants in the evaluation of research and doctoral training were Researcher Communities 
(hereafter referred to as the RC). The RC refers to the group of researchers who registered together in the 
evaluation of their research and doctoral training. Preconditions in forming RCs were stated in the 
Guidelines for the Participating Researcher Communities. The RCs defined themselves whether their 
compositions should be considered well-established or new. 
It is essential to emphasise that the evaluation combines both meta-evaluation1 and traditional 
research assessment exercise and its focus is both on the research outcomes and procedures associated 
with research and doctoral training. The approach to the evaluation is enhancement-led where self-
evaluation constituted the main information. The answers to the evaluation questions formed together 
with the information of publications and other scientific activities an entity that was to be reviewed as a 
whole. 
The present evaluation recognizes and justifies the diversity of research practices and publication 
traditions. Traditional Research Assessment Exercises do not necessarily value high quality research with 
low volumes or research distinct from mainstream research. It is challenging to expose the diversity of 
research to fair comparison. To understand the essence of different research practices and to do justice to 
their diversity was one of the main challenges of the present evaluation method. Understanding the 
divergent starting points of the RCs demanded sensitivity from the evaluators. 
1.2 Aims and objectives in the evaluation 
The aims of the evaluation are as follows: 
 to improve the level of research and doctoral training at the University of Helsinki and to raise 
their international profile in accordance with the University’s strategic policies. The improvement 
of doctoral training should be compared to the University’s policy.2 
 to enhance the research conducted at the University by taking into account the diversity, 
originality, multidisciplinary nature, success and field-specificity, 
 to recognize the conditions and prerequisites under which excellent, original and high-impact 
research is carried out, 
 to offer the academic community the opportunity to receive topical and versatile international 
peer feedback, 
 to better recognize the University’s research potential. 
 to exploit the University’s TUHAT research information system to enable transparency of 
publishing activities and in the production of reliable, comparable data. 
1.3 Evaluation method 
The evaluation can be considered as an enhancement-led evaluation. Instead of ranking, the main aim is to 
provide useful information for the enhancement of research and doctoral training of the participating RCs. 
The comparison should take into account each field of science and acknowledge their special character. 
                                                                
1 The panellists did not read research reports or abstracts but instead, they evaluated answers to the evaluation 
questions, tables and compilations of publications, other scientific activities, bibliometrics or comparable analyses. 
2
 Policies on doctoral degrees and other postgraduate degrees at the University of Helsinki.  
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The comparison produced information about the present status and factors that have lead to success. Also 
challenges in the operations and outcomes were recognized. 
The evaluation approach has been designed to recognize better the significance and specific nature of 
researcher communities and research areas in the multidisciplinary top-level university. Furthermore, one 
of the aims of the evaluation is to bring to light those evaluation aspects that differ from the prevalent 
ones. Thus the views of various fields of research can be described and research arising from various 
starting points understood better. The doctoral training is integrated into the evaluation as a natural 
component related to research. Operational processes of doctoral training are being examined in the 
evaluation. 
 
Five stages of the evaluation method were: 
1. Registration – Stage 1 
2. Self-evaluation – Stage 2 
3. TUHAT3 compilations on publications and other scientific activities4 
4. External evaluation 
5. Public reporting 
1.4 Implementation of the external evaluation 
Five Evaluation Panels 
Five evaluation panels consisted of independent, renowned and highly respected experts. The main 
domains of the panels are: 
1. biological, agricultural and veterinary sciences 
2. medicine, biomedicine and health sciences 
3. natural sciences 
4. humanities 
5. social sciences 
The University invited 10 renowned scientists to act as chairs or vice-chairs of the five panels based on 
the suggestions of faculties and independent institutes. Besides leading the work of the panel, an 
additional role of the chairs was to discuss with other panel chairs in order to adopt a broadly similar 
approach. The panel chairs and vice-chairs had a pre-meeting on 27 May 2011 in Amsterdam. 
The panel compositions were nominated by the Rector of the University 27 April 2011. The participating 
RCs suggested the panel members. The total number of panel members was 50. The reason for a smaller 
number of panellists as compared to the previous evaluations was the character of the evaluation as a 
meta-evaluation. The panellists did not read research reports or abstracts but instead, they evaluated 
answers to the evaluation questions, tables and compilations of publications, other scientific activities, 
bibliometrics and comparable analyses. 
 
The panel meetings were held in Helsinki: 
 On 11–13 September 2011: (1) biological, agricultural and veterinary sciences, (2) medicine, 
biomedicine and health sciences and (3) natural sciences.  
 On 18–20 September 2011: (4) humanities and (5) social sciences. 
  
                                                                
3 TUHAT (acronym) of Research Information System (RIS) of the University of Helsinki 
4 Supervision of thesis, prizes and awards, editorial work and peer reviews, participation in committees, boards and 
networks and public appearances. 
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1.5 Evaluation material 
The main material in the evaluation was the RCs’ self-evaluations that were qualitative in character and 
allowed the RCs to choose what was important to mention or emphasise and what was left unmentioned. 
The present evaluation is exceptional at least in the Finnish context because it is based on both the 
evaluation documentation (self-evaluation questions, publications and other scientific activities) and the 
bibliometric reports. All documents were delivered to the panellists for examination. 
Traditional bibliometrics can be reasonably done mainly in medicine, biosciences and natural sciences 
when using the Web of Science database, for example. Bibliometrics, provided by CWTS/The Centre for 
Science and Technology Studies, University of Leiden, cover only the publications that include WoS 
identification in the TUHAT-RIS. 
Traditional bibliometrics are seldom relevant in humanities and social sciences because the 
international comparable databases do not store every type of high quality research publications, such as 
books and monographs and scientific journals in other languages than English. The Helsinki University 
Library has done analysis to the RCs, if their publications were not well represented in the Web of Science 
databases (RCs should have at least 50 publications and internal coverage of publications more than 40%) 
– it meant 58 RCs. The bibliometric material for the evaluation panels was available in June 2011. The RC-
specific bibliometric reports are attached at the end of each report. 
The panels were provided with the evaluation material and all other necessary background information, 
such as the basic information about the University of Helsinki and the Finnish higher education system. 
 
Evaluation material 
1. Registration documents of the RCs for the background information 
2. Self evaluation material – answers to the evaluation questions 
3. Publications and other scientific activities based on the TUHAT RIS: 
3.1. statistics of publications 
3.2. list of publications 
3.3. statistics of other scientific activities 
3.4. list of other scientific activities 
4. Bibliometrics and comparable analyses: 
4.1. Analyses of publications based on the verification of TUHAT-RIS publications with the Web 
of Science publications (CWTS/University of Leiden) 
4.2. Publication statistics analysed by the Helsinki University Library - mainly for humanities and 
social sciences 
5. University level survey on doctoral training (August 2011) 
6. University level analysis on publications 2005–2010 (August 2011) provided by CWTS/University 
of Leiden 
 
Background material 
 
University of Helsinki 
- Basic information about the University of the Helsinki 
- The structure of doctoral training at the University of Helsinki 
- Previous evaluations of research at the University of Helsinki – links to the reports: 1998 and 2005 
 
The Finnish Universities/Research Institutes 
- Finnish University system 
- Evaluation of the Finnish National Innovation System 
- The State and Quality of Scientific Research in Finland. Publication of the Academy of Finland 
9/09. 
 
The evaluation panels were provided also with other relevant material on request before the meetings in 
Helsinki. 
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1.6 Evaluation questions and material 
The participating RCs answered the following evaluation questions which are presented according to the 
evaluation form. In addition, TUHAT RIS was used to provide the additional material as explained. For 
giving the feedback to the RCs, the panellists received the evaluation feedback form constructed in line 
with the evaluation questions: 
 
1. Focus and quality of the RC’s research 
 Description of 
- the RC’s research focus. 
- the quality of the RC’s research (incl. key research questions and results) 
- the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
The additional material: TUHAT compilation of the RC’s publications, analysis of the RC’s publications data 
(provided by University of Leiden and the Helsinki University Library) 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
2. Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
- recruitment and selection of doctoral candidates 
- supervision of doctoral candidates 
- collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
- good practises and quality assurance in doctoral training 
- assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
The additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
3. The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with 
public, private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral 
training. 
The additional material: TUHAT compilation of the RC’s other scientific activities. 
A written feedback from the aspects of: societal impact, national and international collaboration, 
innovativeness 
 
  Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
 
 
 
9 
 
4. International and national (incl. intersectoral) research collaboration and researcher mobility 
 Description of  
- the RC’s research collaborations and joint doctoral training activities 
- how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and 
researcher mobility, and the actions planned for their development. 
A written feedback from the aspects of: scientific quality, national and international collaboration 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
5. Operational conditions  
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the 
actions planned for their development. 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
6. Leadership and management in the researcher community 
 Description of 
- the execution and processes of leadership in the RC 
- how the management-related responsibilities and roles are distributed in the RC 
- how the leadership- and management-related processes support 
- high quality research 
- collaboration between principal investigators and other researchers in the RC 
the RC’s research focus 
- strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and 
the actions planned for developing the processes 
 
7. External competitive funding of the RC 
 The RCs were asked to provide information of such external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, TEKES/The 
Finnish Funding Agency for Technology and Innovation , EU, ERC, foundations, other national funding 
organisations, other international funding organisations), and 
2)The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
 
Competitive funding reported in the text is also to be considered when evaluating this point. 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness, future significance 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
8. The RC’s strategic action plan for 2011–2013 
 RC’s description of their future perspectives in relation to research and doctoral training. 
A written feedback from the aspects of: scientific quality, scientific significance, societal Impact, processes 
and good practices related to leadership and management, national and international collaboration, 
innovativeness, future significance 
 Strengths 
 Areas of development 
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 Other remarks 
 Recommendations 
 
9. Evaluation of the category of the RC in the context of entity of the evaluation material (1-8) 
 
The RC’s fitness to the chosen participation category 
A written feedback evaluating the RC’s fitness to the chosen participation category  
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
10. Short description of how the RC members contributed the compilation of the stage 2 material 
Comments on the compilation of evaluation material 
 
11. How the UH’s focus areas are presented in the RC’s research? 
Comments if applicable 
 
12. RC-specific main recommendations based on the previous questions 1–11 
 
13. RC-specific conclusions 
1.7 Evaluation criteria 
The panellists were expected to give evaluative and analytical feedback to each evaluation question 
according to their aspects in order to describe and justify the quality of the submitted material. In 
addition, the evaluation feedback was asked to be pointed out the level of the performance according to 
the following classifications: 
 outstanding  (5) 
 excellent  (4) 
 very good  (3) 
 good   (2) 
 sufficient  (1) 
 
Evaluation according to the criteria was to be made with thorough consideration of the entire 
evaluation material of the RC in question. Finally, in questions 1-4 and 9, the panellists were expected to 
classify their written feedback into one of the provided levels (the levels included respective descriptions, 
‘criteria’). Some panels used decimals in marks. The descriptive level was interpreted according to the 
integers and not rounding up the decimals by the editors. 
 
Description of criteria levels 
Question 1 – FOCUS AND QUALITY OF THE RC’S RESEARCH 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Outstandingly strong research, also from international perspective. Attracts great international 
interest with a wide impact, including publications in leading journals and/or monographs published 
by leading international publishing houses. The research has world leading qualities. The research 
focus, key research questions scientific significance, societal impact and innovativeness are of 
outstanding quality. 
In cases where the research is of a national character and, in the judgement of the evaluators, should 
remain so, the concepts of ”international attention” or ”international impact” etc. in the grading 
criteria above may be replaced by ”international comparability”. 
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Operations and procedures are of outstanding quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are in 
alignment with the documentation. The ambition to develop the community together is of 
outstanding quality. 
Excellent quality of procedures and results (4) 
Research of excellent quality. Typically published with great impact, also internationally. Without 
doubt, the research has a leading position in its field in Finland. 
Operations and procedures are of excellent quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of excellent quality. 
Very good quality of procedures and results (3) 
The research is of such very good quality that it attracts wide national and international attention. 
Operations and procedures are of very good quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of very good quality. 
Good quality of procedures and results (2) 
Good research attracting mainly national attention but possessing international potential, 
extraordinarily high relevance may motivate good research. 
Operations and procedures are of good quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to large extent in alignment with the documentation. The ambition to develop the 
community together is of good quality. 
Sufficient quality of procedures and results (1) 
In some cases the research is insufficient and reports do not gain wide circulation or do not have 
national or international attention. Research activities should be revised. 
Operations and procedures are of sufficient quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to some extent in alignment with the documentation. The ambition to develop the 
community together is of sufficient quality. 
 
Question 2 – DOCTORAL TRAINING 
Question 3 – SOCIETAL IMPACT 
Question 4 – COLLABORATION 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Procedures are of outstanding quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are in alignment with the 
documentation. The ambition to develop the community together is of outstanding quality. The 
procedures and results are regularly evaluated and the feedback has an effect on the planning. 
Excellent quality of procedures and results (4) 
Procedures are of excellent quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of excellent quality. The 
procedures and outcomes are evaluated and the feedback has an effect on the planning. 
Very good quality of procedures and results (3) 
Procedures are of very good quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
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management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of very good quality. 
Good quality of procedures and results (2) 
Procedures are of good quality, shared occasionally in the community. The practices and quality of 
doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of good quality. 
Sufficient quality of procedures and results (1) 
Procedures are of sufficient quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are occasionally documented and operations and practices are to some extent in 
alignment with the documentation. The ambition to develop the community together is of sufficient 
quality. 
 
Question 9 – CATEGORY 
Participation category – fitness for the category chosen 
The choice and justification for the chosen category below should be reflected in the RC’s responses to the 
evaluation questions 1–8. 
1. The research of the participating community represents the international cutting edge in its field. 
2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
3. The research of the participating community is distinct from mainstream research, and the special 
features of the research tradition in the field must be considered in the evaluation. The research is 
of high quality and has great significance and impact in its field. However, the generally used 
research evaluation methods do not necessarily shed sufficient light on the merits of the 
research.  
4. The research of the participating community represents an innovative opening. A new opening can 
be an innovative combination of research fields, or it can be proven to have a special social, 
national or international demand or other significance. Even if the researcher community in its 
present composition has yet to obtain proof of international success, its members can produce 
convincing evidence of the high level of their previous research. 
5. The research of the participating community has a highly significant societal impact. The 
participating researcher community is able to justify the high social significance of its research. 
The research may relate to national legislation, media visibility or participation in social debate, 
or other activities promoting social development and human welfare. In addition to having 
societal impact, the research must be of a high standard. 
 
An example of outstanding fitness for category choice (5) 5 
The RC’s representation and argumentation for the chosen category were convincing. The RC recognized 
its real capacity and apparent outcomes in a wider context to the research communities. The specific 
character of the RC was well-recognized and well stated in the responses. The RC fitted optimally for the 
category. 
 
 Outstanding  (5) 
 Excellent  (4) 
 Very good  (3) 
 Good   (2) 
 Sufficient  (1) 
The above-mentioned definition of outstanding was only an example in order to assist the panellists in 
the positioning of the classification. There was no exact definition for the category fitness. 
                                                                
5 The panels discussed the category fitness and made the final conclusions of the interpretation of it. 
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1.8 Timetable of the evaluation 
The main timetable of the evaluation: 
1. Registration   November 2010 
2. Submission of self-evaluation materials  January–February 2011 
3. External peer review    May–September 2011 
4. Published reports    March–April 2012 
- University level public report 
- RC specific reports 
 
The entire evaluation was implemented during the university’s strategy period 2010–2012. The preliminary 
results were available for the planning of the following strategy period in late autumn 2011. The evaluation 
reports will be published in March/April 2012. More detailed time schedule is published in the University 
report. 
1.9 Evaluation feedback – consensus of the entire panel 
The panellists evaluated all the RC-specific material before the meetings in Helsinki and mailed the 
draft reports to the evaluation office. The latest interim versions were on-line available to all the panellists 
on the Wiki-sites. In September 2011, in Helsinki the panels discussed the material, revised the first draft 
reports and decided the final numeric evaluation. After the meetings in Helsinki, the panels continued 
working and finalised the reports before the end of November 2011. The final RC-specific reports are the 
consensus of the entire panel. 
The evaluation reports were written by the panels independently. During the editing process, the 
evaluation office requested some clarifications from the panels when necessary. The tone and style in the 
reports were not harmonized in the editing process. All the reports follow the original texts written by the 
panels as far as it was possible. 
The original evaluation material of the RCs, provided for the panellists is attached at the end of the 
report. It is essential to notice that the exported lists of publications and other scientific activities depend 
how the data was stored in the TUHAT-RIS by the RCs. 
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2 Evaluation feedback 
2.1 Focus and quality of the RC’s research 
 Description of 
 the RC’s research focus 
 the quality of the RC’s research (incl. key research questions and results) 
 the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness 
 
The RC is divided into four main topics: cardiovascular pharmacology, regenerative therapy, 
nutrition/functional food and clinical cardiology/hypertension genetics within a relative small RC size, 
especially when divided into four main topics. This breadth raises concerns over the research focus of the 
RC. 
They have produced a high productivity on papers with generally good impact and citation rates as 
well as some IP with patents, although efforts should be made to increase the impact of publications 
especially those categorized as food science and technology to enhance international standing of these 
works. Despite the diversity in topics, they managed in different interdisciplinary and translational 
approaches, the balance of basic and clinical sciences, as well as their promising merging. 
New therapeutical approaches with new medical entities in combination with international core 
programs or international associations resulted in a heterogeneous, but successful RC. 
The thematic overlap in some of the main topics may require further focus for internal RC cooperation 
in addition when considering expanding connections to other topics related RCs within UH. 
Numeric evaluation: 3 (Very good) 
2.2 Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
 recruitment and selection of doctoral candidates 
 supervision of doctoral candidates 
 collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
 good practises and quality assurance in doctoral training 
 assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
 Additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
ASPECTS: Processes and good practices related to leadership and management 
 
There is a good training program for the PhD students. The outlook for good positions is good although 
the general number of free position for excellent academics is limited. The teaching work-load for the PhD 
students as well as for the supervisors at different levels is not clear, but the impression is given that there 
is an overload or imbalance of too much teaching and a smaller part for research. 
Detail of the overall duration of PhD studies should be provided and, as with numerous RCs, it seems to 
be much longer than the internationally accepted three to four years. The workload for PhD students 
should be given in more details and more attention given to the important role of the PhD thesis 
committee. 
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An alumni register would be helpful to follow the career of the former students. 
The international exchange can be enlarged by sending the PhD students to foreign labs. Here the 
installation of European networks and grants would be helpful. 
With the different institutes there appears to be different PhD student programs. With a general core 
structure for a number of RCs or institutes, complimented by different specialized course for the detailed 
programmes of the RC, the work-load may be reduced. 
It is not clear if it is free to choose from one to three supervisors. A number of two to three seems to be 
more appropriate. An increase of meetings for PhD committees from a minimum of one per annum would 
benefit doctoral students and help to direct and improve the mentoring and advisory support by 
supervisors. 
The gender problem can be raised in general terms in respect to the higher classification of students 
and PhD students. It is not restricted to this RC, but a general question. 
Another general problem is related to the career development after PhD graduation. 
Numeric evaluation: 3 (Very good) 
2.3 The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral training. 
 Additional material: TUHAT compilation of the RC’s other scientific activities. 
ASPECTS: Societal impact, national and international collaboration, innovativeness 
 
The RC members are involved in different national scientific organizations and have taken over leadership 
responsibilities. As clinical research usually has more direct and therefore, larger impact on society, this 
may be stressed with further popular contributions to community. It should be stated that the already 
achieved social and public effects are at a very good level. 
Numeric evaluation: 3 (Very good) 
2.4 International and national (incl. intersectoral) research 
collaboration and researcher mobility 
 Description of  
 the RC’s research collaborations and joint doctoral training activities 
 how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and researcher 
mobility, and the actions planned for their development. 
ASPECTS: Scientific quality, national and international collaboration 
 
The RC has carried out very well concerning the international exchange and cooperation with broad 
contacts all over the world with some clear focus on Europe. The exchange has been productive in both 
ways. International winter schools are productive in developing positive multinational interactions. 
Numerous exchange programs are performed with other European countries including on joint doctoral 
training. 
Numeric evaluation: 4 (Excellent) 
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2.5 Operational conditions 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the actions 
planned for their development. 
ASPECTS: Processes and good practices related to leadership and management 
 
Research is performed in a modern laboratory space. 
Administrative work and teaching duties seem to take a lot of time from research. UH should take care 
that an appropriate balance can be maintained. 
The room facilities and the conditions of instruments are unclear from the broad description. 
2.6 Leadership and management in the researcher community 
 Description of  
 the execution and processes of leadership in the RC 
 how the management-related responsibilities and roles are distributed in the RC 
 how the leadership- and management-related processes support 
 high quality research 
 collaboration between principal investigators and other researchers in the RC 
 the RC’s research focus 
 strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and the 
actions planned for developing the processes 
ASPECTS: Processes and good practices related to leadership and management 
 
Different members of the RC have successfully taken leadership roles in different national and 
international organisations. 
2.7 External competitive funding of the RC 
• The RCs were asked to provide information of such external competitive funding, where: 
• the funding decisions have been made during 1.1.2005–31.12.2010, and  
• the administrator of the funding is/has been the University of Helsinki 
• On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, 
TEKES/The Finnish Funding Agency for Technology and Innovation, EU, ERC, foundations, other 
national funding organisations, other international funding organizations), and 
2) The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
Competitive funding reported in the text is also to be considered when evaluating this point. 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness and future significance 
 
The level of external grants for funding research at circa €3.8m is good with funding from the Academy of 
Finland, TEKES, Finnish Foundation for CV Research, and EVO-funding as well as the pharmaceutical and 
food industries. With an absence of funding from the EU, the RC is advised to examine ways to secure 
grants or be involved in collaborative programmes from this source. 
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2.8 The RC’s strategic action plan for 2011–2013 
• RC’s description of their future perspectives in relation to research and doctoral training. 
ASPECTS: Scientific quality, scientific significance, societal Impact, processes and good practices related to 
leadership and management, national and international collaboration, innovativeness, future significance 
 
For the near future the current activities of the RC should be further supported in the different 
interdisciplinary and translational steps in basic and clinical research. 
The interaction between the main topics and the groups within the RC should be strengthened. 
As the communication and exchange with national and international scientist is already at a high level 
the communication of scientific findings to publicity should be operating at the same level. 
In some cases nutrition and genetics play major roles and the problem/topic of epigenetics may be 
considered by the RC at an early stage in the future. 
2.9 Evaluation of the category of the RC in the context of entity of 
the evaluation material (1-8) 
The RC’s fitness to the chosen participation category. 
Category 2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
 
The RC is one of the national leading research teams with good quality in international research. 
Within the relative small RC size, they have achieved a very good performance in research and doctoral 
training, and good visibility. 
Participation category 2 ‘The research of the participating community is of high quality, but the 
community in its present composition has yet to achieve strong international recognition or a clear break-
through’ is appropriate at this stage of development of the RC. 
Numeric evaluation: 4 (Excellent) 
2.10 Short description of how the RC members contributed the 
compilation of the stage 2 material 
The processes employed were fair and appropriate. 
2.11 How the UH’s focus areas are presented in the RC’s research 
Focus area 6: Clinical research 
 
The selected UH focus area 6 – ‘Clinical research’ – is appropriate for the research activities of the RC. 
2.12 RC-specific main recommendations 
The leading national status of the RC in its fields of research and doctoral training were recognized by the 
Panel and continuing activities are encouraged. In order to add value and to improve further the 
recognized quality of the work of the RC, major efforts, perhaps via a coordinated approach, should be 
made to publish the outputs of the research in high impact journals, where possible, which will raise the 
profile and international standing and status of the RC. 
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Whilst appreciating the importance of the areas of study and interest of the RC, some concern was 
expressed by the Panel regarding the breadth and scope of the research activities in this relatively small 
RC, and attention to this issue is recommended with consideration given to a more focused portfolio of 
topics. In addition, it is suggested that some clarification of supervisory processes and requirements for 
doctoral students would be beneficial. 
In order to broaden the range of funding opportunities for the group and encourage international 
standing and further contacts, it is suggested that efforts are directed towards securing access to EU 
funding perhaps via contributions to networks or grant applications, and consideration given to achieving 
value from the IP positions created by the RC from the translational research work. 
2.13 RC-specific conclusions 
The Panel was encouraged to note the evidence of the successes of the RC in their research and doctoral 
training programmes and recognize the potential for achieving a stronger international standing and 
position. A key issue in driving this factor is the publication of research findings in high impact journals 
and to secure external international support and funding, such as via EU networks and grants. 
The Panel was also of the view that given the size and dimension of the RC, attention should be given 
to refocusing the somewhat broad portfolio of their research activities, and the RC should reflect on the 
benefits of a consolidation of chosen topics which may be strengthened via cooperation with other RCs 
working in overlapping areas of interest. 
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3 Appendices 
A. Original evaluation material 
a. Registration material – Stage 1 
b. Answers to evaluation questions – Stage 2 
c. List of publications 
d. List of other scientific activities 
B. Bibliometric analyses 
a. Analysis provided by CWTS/University of Leiden 
b. Analysis provided by Helsinki University Library (66 RCs) 
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at the University of Helsinki 2005-2010 
 
         RC-SPECIFIC MATERIAL FOR THE PEER REVIEW 
 
 
 
 
NAME OF THE RESEARCHER COMMUNITY:  
Cardiovascular Medicine (CardioMed) 
 
LEADER OF THE RESEARCHER COMMUNITY:  
Professor Eero Mervaala, Institute of Biomedicine, Faculty of Medicine 
 
 
RC-SPECIFIC MATERIAL FOR THE PEER REVIEW: 
 Material submitted by the RC at stages 1 and 2 of the evaluation 
- STAGE 1 material: RC’s registration form (incl. list of RC participants in an excel table) 
- STAGE 2 material: RC’s answers to evaluation questions 
 TUHAT compilations of the RC members’ publications 1.1.2005-31.12.2010 
 TUHAT compilations of the RC members’ other scientific activities 1.1.2005-31.12.2010 
 Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010 
(analysis carried out by CWTS, Leiden University) 
NB! Since Web of Science(WoS)-based bibliometrics does not provide representative results for most RCs representing 
humanities, social sciences and computer sciences, the publications of these RCs will be analyzed by the UH Library 
(results available by the end of June, 2011) 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
 
 
Name: Mervaala, Eero 
E-mail:  
Phone: 09-19125355 
Affiliation: Institute of Biomedicine 
Street address: P.O.BOX 63 (Haartmaninkatu 8) 00014 University of Helsinki 
 
 
Name of the participating RC (max. 30 characters): Cardiovascular Medicine 
Acronym for the participating RC (max. 10 characters): CardioMed 
Description of the operational basis in 2005-2010 (eg. research collaboration, joint doctoral training 
activities) on which the RC was formed (MAX. 2200 characters with spaces): CardioMed is a research 
community between several research groups working in the field of cardiovascular medicine. The research 
groups are located in the Institute of Biomedicine (pharmacology, physiology), and Department of Clinical 
Medicine. Cardiovascular Research in CardioMed is conducted in a highly interdisciplinary way, through a 
meaningful combination of basic and clinical research and international collaboration. CardioMed provides 
a framework in which researchers can carry out their scientific work at high level, and translate their 
findings into new forms of prevention, diagnostics, and therapies of cardiovascular diseases. The research 
community is based on long-lasting research collaboration between the principal investigators as well as on 
joint doctoral training. The research community combines their expertise on preclinical cardiovascular 
pharmacology and drug development, nutritional research and functional foods, regenerative therapy as 
well as on clinical medicine and hypertension genetics. Some of the principal investigators in CardioMed 
(professor Korpela, professor Mervaala and docent Tikkanen (coordinator)) are members of the Helsinki 
Hypertension Centre of Excellence (Helsinki University Central Hospital). Docent Kankuri, docent Tikkanen 
and professor Harjula are members of international Core-to-Core Program on Regenerative Therapy. The 
groups led by Professor Korpela and professor Mervaala have been selected as participants in a novel 
research consortium “Strategic Centre for Health and Wellbeing Salve Ltd”.  The following group leaders are 
board members of the Finnish Hypertension Society (Mervaala (president), Tikkanen, Hiltunen). 
 
 
Main scientific field of the RC’s research: medicine, biomedicine and healt sciences 
RC's scientific subfield 1: Cardiac and Cardiovascular System 
RC's scientific subfield 2: Pharmacology and Pharmacy 
RC's scientific subfield 3: Nutrition and Dietetics 
RC's scientific subfield 4: Medicine, Research and Experimental 
1 RESPONSIBLE PERSON 
2 DESCRIPTION OF THE PARTICIPATING RESEARCHER COMMUNITY (RC) 
3 SCIENTIFIC FIELDS OF THE RC 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
Other, if not in the list:  
 
 
Participation category: 2. Research of the participating community is of high quality, but the community in 
its present composition has yet to achieve strong international recognition or a clear break-through 
Justification for the selected participation category (MAX. 2200 characters with spaces):  CardioMed is a 
novel Research Community, the investigators are relatively young, and the  size of the Research Community 
relatively small. Therefore the community has not yet been able to achieve strong international recognition 
or a clear break-through. Professor Mervaala was nominated as full-time professor of Cardiovascular and 
Metabolic Pharmacology in the Institute of Biomedicine in 2008, and professor Korpela as professor of 
Medical Nutrition Physiology later in 2008. 
 
 
Public description of the RC's research and doctoral training (MAX. 2200 characters with spaces): The 
research activities in CardioMed are organized in 4 main topics: (1) Cardiovascular pharmacology, (2) 
Regenerative therapy, (3) Nutrition/functional foods, (4) Clinical cardiology/hypertension genetics.  
Cardiovascular Pharmacology Group led by professor Eero Mervaala. The group investigate the molecular 
mechanisms of cardiac hypertrophy and heart failure with a special interest on local renin-angiotensin 
system, inflammation, novel angiogenic factors (VEGF-family members), mitochondrial function, and drug 
development (calcium sensitizers, in collobaration with pharmaceutical industry).  
Regenerative Therapy led by docent Esko Kankuri and professor Ari Harjula. Kankuri’s and Harjula’s groups 
participate on international Core-to-Core Program on Regenerative Therapy aiming at construction of 
cardiac tissue using integrated gene, cell, and tissue engineering technology and its application for the 
treatment of cardiac failure.  
Nutrition/Functional Foods is led by professor Riitta Korpela and professor Heikki Vapaatalo. Korpela’s 
group is regarded as one of the frontier groups in the area of functional foods. The group uses both in vitro 
and animal models and has a long experience in clinical trials. Both groups will investigate pharmacological 
and physiological effects of novel milk protein-derived biopeptides in preclinical and clinical studies. They 
aim at developing novel antihypertensive and cholesterol-lowering functional food items in collaboration 
with food industry.  
Clinical cardiology/hypertension genetics is led by docent Ilkka Tikkanen. Tikkanen acts also as the 
coordinator of Helsinki Hypertension Centre of Excellence in Helsinki University Central Hospital. Tikkanen’s 
group studies end-organ and tissue damage secondary to cardiovascular, heart and kidney diseases and the 
molecular mechanisms involved herein. Docent Jukka Lehtonen’s research interest lies within renin-
angiotensin system and inflammatory heart diseases. Docent Timo Hiltunen’s research covers monogenic 
forms and pharmacogenetics of hypertension. 
Significance of the RC's research and doctoral training for the University of Helsinki (MAX. 2200 
characters with spaces): CardioMed’s research is interdisciplinary and translational, and combines basic 
and clinical research. The RC produces experts in the several fields (in particular pharmacology), with high 
employment opportunity in the Finnish Medicines Agency or in the pharmaceutical/food industry. 
4 RC'S PARTICIPATION CATEGORY 
5 DESCRIPTION OF THE RC'S RESEARCH AND DOCTORAL TRAINING 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
CardioMed has an excellent track record in doctoral training and mentoring, and the members of 
CardioMed have are very actively taken part into teaching duties in the Medical Faculty. CardioMed 
provides an excellent infrastructure for integrated Cardiovascular Medicine and translational research. 
CardioMed addresses areas of general public interest and impact, as cardiovascular diseases are the leading 
cause of death and disability in the developed countries. 
Keywords: Cardiovascular pharmacology; Regenerative medicine, Cell therapy, Personalized medicine; 
Pharmacogenetics; Drug development; Nutrition; Functional foods; Metabolism; Translational Research; 
Inflammation 
 
 
Justified estimate of the quality of the RC's research and doctoral training at national and international 
level during 2005-2010 (MAX. 2200 characters with spaces): CardioMed is a novel Research Community, 
and therefore the quality of CardioMed’s research and doctoral training has not been evaluated with 
justification during the period under evaluation. However, all the research groups have received substantial 
external funding during the period under evaluation (Academy of Finland, Sigrid Juselius Foundation, 
National Technology Agency, University of Helsinki, Helsinki University Central Hospital) indicating high 
quality of their research and doctoral training. 
Comments on how the RC's scientific productivity and doctoral training should be evaluated (MAX. 2200 
characters with spaces): For methods of assessing CardioMed’s scientific productivity and doctoral training 
we suggest the following: 1) amount of external funding, 2) number of doctoral candidates who have 
finished their PhD studies during the period under evaluation, 3) number of publications and quality of the 
publications, 4) number of patents/patent applications. 
It should also be underlined that all principal investigators, post-doctoral researchers and doctoral 
candidates working in the Institute of Biomedicine have a substantial amount of teaching duties, since 
Institute of Biomedicine is responsible for the first two years’ courses for medical students and dentists, as 
well as for TRANSMED-Master of Science program. Such teaching load should be taken into consideration 
when evaluating the CardioMed research community. 
6 QUALITY OF RC'S RESEARCH AND DOCTORAL TRAINING 
LIST OF RC MEMBERS
NAME OF THE RESEARCHER COMMUNITY: CardioMed
RC-LEADER E. Mervaala
CATEGORY 2
Last name First name
PI-status 
(TUHAT-
check, 
lista 29.11.)
Title of research and 
teaching personnel Affiliation 
1 Mervaala Eero x Professor Faculty of Medicine, Institute of Biomedicine
2 Korpela Riitta x Professor Faculty of Medicine, Institute of Biomedicine
3 Vapaatalo Heikki x Professor Faculty of Medicine, Institute of Biomedicine
4 Harjula Ari x Professor Faculty of Medicine, Institute of Clinical Medicine
5 Tikkanen Ilkka x Research Director Faculty of Medicine, Institute of Clinical Medicine
6 Kankuri Esko x Senior Researcher Faculty of Medicine, Institute of Biomedicine
7 Laine Mika Senior Researcher Faculty of Medicine, Institute of Clinical Medicine
8 Finckenberg Piet Post-doctoral Researcher Faculty of Medicine, Institute of Biomedicine
9 Louhelainen Marjut Doctoral candidate Faculty of Medicine, Institute of Biomedicine
10 Biala Agnieszka Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
11 Ketonen Juha Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
12 Kaheinen Petri Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
13 Pilvi Taru Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
14 Pere Anna-Kaisa Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
15 Vahtola Erik Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
16 Tauriainen Eveliina Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
17 Shi Jin Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
18 Lempiäinen Juha Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
19 Ehlers (neé Jäkälä) Pauliina Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
20 Jauhiainen Tiina Post-doctoral researcher Faculty of Medicine, Institute of Biomedicine
21 Lakkisto Päivi Doctoral Candidate Faculty of Medicine, Institute of Clinical Medicine
22 Paavola Jere Doctoral Candidate Faculty of Medicine, Institute of Clinical Medicine
23 Forsten Hanna Doctoral Candidate Faculty of Medicine, Institute of Clinical Medicine
24 Segersvärd Heli Doctoral Candidate Faculty of Medicine, Institute of Clinical Medicine
25 Siren Juuso Doctoral Candidate Faculty of Medicine, Institute of Clinical Medicine
26 Bäcklund Tom Doctoral Candidate Faculty of Medicine, Institute of Clinical Medicine
27 Grönholm Tina Doctoral Candidate Faculty of Medicine, Institute of Clinical Medicine
28 Siltanen Antti Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
29 Nuutila Kristo Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
30 Peura Matti Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
31 Aarnio Karoliina Doctoral Candidate Faculty of Medicine, Institute of Biomedicine
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Name of the RC’s responsible person: Mervaala, Eero 
E-mail of the RC’s responsible person:   
Name and acronym of the participating RC: Cardiovascular Medicine, CARDIOMED 
The RC’s research represents the following key focus area of UH: 6. Kliininen tutkimus – Clinical research 
Comments for selecting/not selecting the key focus area: Part of the RC’s research represents very closely 
one of the key focus areas of UH, namely clinical research. However, it should be underlined that the RC’s 
research also represents basic and translational research in cardiovascular and nutritional medicine. 
 
 
 Description of the RC’s research focus, the quality of the RC’s research (incl. key research 
questions and results) and the scientific significance of the RC’s research for the research 
field(s).  
Cardiovascular diseases represent a major public health problem and the leading cause of death in 
Finland. RC provides a highly interdisciplinary framework in which cardiovascular research can be carried 
out at high level aiming at translation of novel innovations into medical applications. RC’s research 
addresses clinically important issues such as hypertension, metabolic syndrome, left ventricular 
hypertrophy, myocardial infarction and heart failure. RC has also a strong interest on nutrition, 
regenerative medicine and personalized drug therapy (“pharmacogenetics”).  
 
RC’s research activities are organized in 4 main topics: 1) Cardiovascular and Metabolic Pharmacology 
and drug development, 2) Regenerative Medicine, 3) Medical Nutrition Physiology and development of 
functional foods, and 4) Clinical cardiology, hypertension genetics and personalized drug therapy.  
 
Cardiovascular Pharmacology Group (Institute of Biomedicine, Principal Investigator (PI) prof. Eero 
Mervaala) investigates the pathophysiology of hypertension and the molecular mechanisms of cardiac 
hypertrophy and post-infarct heart failure as well as the mechanisms of cardiovascular aging (funded by 
Academy of Finland 2008-2011). The group showed a key role for local renin-angiotensin system in the 
pathogenesis of cardiac remodelling and cardiovascular aging. It was shown that angiotensin II induces 
oxidative stress, inflammation and mitochondrial dysfunction by blood pressure- independent 
mechanisms. Metabolomics analysis revealed distinct energy substrate utilization in cardiac 
hypertrophy. The group has evaluated the potential of novel oral calcium sensitizers in the treatment of 
heart failure (two patents). In collaboration with prof. Kari Alitalo’s group we have investigated the role 
of angiogenic factors as coronary growth factors and regulators of cardiac growth and metabolism. It 
was found that VEGF-B acts as a growth factor without inducing angiogenesis, vascular leak, or 
inflammation. VEGF-B also altered lipidomic profile in the heart and induced cardiac hypertrophy via 
blood pressure-independent mechanisms. The group has collaborated with food industry to generate 
novel nutritional strategies to combat obesity (one patent) and to develop novel salt alternatives for 
hypertension control (patent application). Finally, the group has started a project to investigate the 
therapeutic role of small molecule compounds and stem cells in acute kidney injury. Prof. Mervaala has 
supervised 6 PhD theses between years 2005-2010, and four PhD thesis will be finished in year 2011 
(under evaluation).   
 
BACKGROUND INFORMATION 
1 FOCUS AND QUALITY OF RC'S RESEARCH (MAX. 8800 CHARACTERS WITH SPACES) 
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Regenerative Pharmacology Group (Institute of Biomedicine/Institute of Clinical Medicine). The team 
led by professor Ari Harjula and docent Esko Kankuri focuses on cardiac regenerative therapies using cell 
sheet technology, nemosis-activated fibroblasts, stem and precursor cells. Cell sheets that are 
transplanted topically on myocardium help to solve the problem of fatal arrhythmias as associated with 
intramyocardial cell injections. Using this technique we have shown for example that bcl-2-mediated 
anti-apoptotic protection helps early myoblast sheet survival. Our preclinical research focuses on 
development of methodology (gene therapy, pharmacotherapy) to enhance regenerative cell sheet 
transplantation therapy. Furthermore we aim at discovery of functional indicators and molecular 
predictors of cell transplant clinical efficacy. In May 2011 we will complete a randomized double-blinded 
clinical trial on intramyocardial stem cell transplantation at coronary artery bypass graft surgery. The 
study provides the first placebo-controlled evidence using functional cardiac magnetic-resonance 
imaging on the efficacy of unfractionated bone marrow precursor cell transplantation therapy in heart 
failure patients. We have also established a “Core-to-Core Consortium” together with professor Axel 
Haverich from the Hannover Medical School, Division of Thoracic & Cardio Surgery, Hannover, Germany 
and with professor Yoshiki Sawa from the Osaka University Graduate School of Medicine, Osaka, Japan. 
The aim is to provide clinical proof of concept for heart failure therapy using autologous myoblast and 
bone marrow stromal/stem cell sheets. We coordinate additional five European clinical cardiac centers 
and cell sheet manufacturing at Finnish Red Cross Blood Service. 
 
Medical Nutrition Physiology Group (Institute of Biomedicine, PIs prof. Riitta Korpela and prof. Heikki 
Vapaatalo) combines translational research to clinical medicine. The group investigates health effects of 
nutritional components (milk, berries, plant sterols) and their mechanisms of action. The main focus has 
been on milk casein-derived tripeptides (Ile-Pro-Pro, Val-Pro-Pro). The group has shown in experimental 
models of hypertension, that milk tripeptides decrease blood pressure and improve vascular function. 
The mechanisms mediating the antihypertensive and vasculoprotective effects of milk tripeptides 
involve inhibition of angiotensin converting enzyme, central regulation of blood pressure and vascular 
homeostasis (one patent). Recently, the group has examined the effects of tripeptides on 
neurodegeneration and retinal blood flow in collaboration with pharmaceutical industry (Santen, 
Pharmatory) (one patent). The group has participated in several clinical studies where the 
antihypertensive effect of tripeptides was demonstrated in mildly hypertensive subjects. These findings 
have been translated into novel functional food items that are in the market in EU and Japan. Prof. 
Vapaatalo has supervised 3 PhD theses (plus 2 PhD projects in progress) and has produced more than 30 
original articles on milk peptides between years 2005-2010. Prof. Korpela has supervised 8 PhD theses 
during the evaluation period, and currently she acts also as a coordinator in a novel research consortium 
“Strategic Centre for Health and Wellbeing SalWe Ltd”.  
 
Unit of Cardiovascular Research (Institute of Clinical Medicine/ Minerva Foundation Institute for Medical 
Research, PI docent Ilkka Tikkanen). The group studies mechanisms and repair of end-organ damage in 
cardiovascular and renal diseases in experimental animals and clinical trials. In this context the local 
expression of components of the renin-angiotensin-aldosterone system, other vasoactive factors and 
apoptosis in hypertension, heart failure, and in progression of renal damage has been studied. In 
addition, the cardiovascular and renal protective properties of new cardiovascular drugs have been 
evaluated. The group was able to demonstrate that calcium signalling in cardiac cells is altered in familial 
catecholaminergic polymorphic ventricular tachycardia due to mutated ryanodine receptors 
predisposing to cardiac arrhythmias in these patients. The group showed that the activity of bradykinin 
degrading enzyme neutral endopeptidase was increased in stenotic aortic valves in parallel with 
increased expression of bradykinin receptors suggesting a therapeutic role for NEP-inhibitory 
compounds. In clinical hypertension projects in collaboration with prof. Kimmo Kontula it was shown 
that 1) the CYP2C9 genotype modifies the activity of the renin-angiotensin-aldosterone system and 2) 
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AGTR1 1166C allele is associated with high serum aldosterone levels and low plasma renin activity in 
patients with essential hypertension. Recently, the Unit has focused on exploring the reparative 
mechanisms of cardiac injury after myocardial infarction. These studies showed that induction heme 
oxygenase-1 promotes cardiomyocyte regeneration and angiogenesis after MI. 
 Ways to strengthen the focus and improve the quality of the RC’s research. 
-to deepen the already existing, already working collaboration within the RC  
-to strengthen the translational research approach in the RC by applying the methodology and 
hypotheses created in basic studies to clinical research questions utilizing the available collaboration 
and patient materials in the University Hospital Clinics (Cardiology, Thoracic surgery) and through the 
network within the Helsinki Hypertension Centre of Excellence 
-to strengthen the current collaboration with research groups in research programs in UH (Prof. Kimmo 
Kontula, Research Program of Molecular Medicine; prof. Kari Alitalo, Research Program of Molecule and 
Cancer Biology) as well with the groups working in the field of obesity, diabetes, mitochondria and lipids 
-to strengthen the collaboration with our international collaborators 
-to initiate a PhD Study seminar common to all members of the RC. Seminars will be given by PhD 
students, researchers participating in the RC, and invited speakers.  
- Post-doctoral fellows and international collaboration would strengthen the research. 
 
 
  How is doctoral training organised in the RC? Description of the RC’s principles for recruitment and 
selection of doctoral candidates, supervision of doctoral candidates, collaboration with faculties, 
departments/institutes, and potential graduate schools/doctoral programmes, good practises and 
quality assurance in doctoral training, and assuring good career perspectives for the doctoral 
candidates/fresh doctorates.  
Recruitment and selection of doctoral candidates is based on their excellence in undergraduate studies 
and/or MSc thesis, or an open call.  
 
PhD students in the RC usually have two supervisors of different disciplines and a PhD Thesis 
Committee. The PhD Thesis Committee includes the student, the supervisor(s), and at least two external 
members representing top class specialists in different disciplines. The Members of the PhD Thesis 
Committee are suggested by the student and supervisor, and accepted by the Faculty of Medicine. The 
external members should have substantial knowledge of the field of the project in order to be able to 
give critical comments and to estimate the ongoing project's potential to result in thesis defense. The 
PhD Thesis Committee is keeping regular meetings at least once a year. 
 
The supervisors together with the PhD Thesis Committee are responsible of ensuring that during the 
PhD studies the student gains detailed knowledge of his/her research field as well as adequate 
understanding of the related fields of biomedicine. Like in graduate schools, the goal for the PhD 
student is to achieve a doctoral degree within a four-year period. 
 
PhD students generate a personal study plan including both research and coursework. Following this the 
PhD project is registered at the Faculty of Medicine. 
 
PhD students in the RC will get their theoretical postgraduate training mainly via participating in the 
courses organized by graduate schools and department programs as well as the courses coordinated by 
2 PRACTISES AND QUALITY OF DOCTORAL TRAINING (MAX. 8800 CHARACTERS WITH SPACES) 
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the Faculty of Medicine. The graduate schools also organize a wide variety of practical training courses, 
seminar series, and scientific symposia for graduate students. 
 
Each research group in the RC is organizing their own weekly group meetings. PhD students participate 
actively on these regular meetings.  
 
The Institutes (Institute of Biomedicine, Institute of Clinical Medicine and Minerva Foundation Institute 
for Medical Research) are organizing weekly post-graduate seminar series for PhD students. 
Institute of Biomedicine (Pharmacology) is organizing an annual follow-up meeting for PhD students. In 
this meeting PhD students give presentations on their research project. 
 
PhD students are encouraged to participate in international meetings and congresses, and represent 
their work there. Travel costs are covered mainly by the research groups, and to some extent, by travel 
grants. 
 
A close dialogue with other universities, industry and ”the third sector” is maintained via our own post-
docs working there and still collaborating with the RC group, as well as by inviting key researchers in the 
field to give lectures in our Institute. For industry, mutual interest and successful joint research projects 
with PhD students are important means to recruit potential new employees. Seven of the eight PhDs 
graduated from Medicinal Nutrition Physiology Group during the evaluation time are employed by 
industry at the moment. 
 RC’s strengths and challenges related to the practises and quality of doctoral training, and the actions 
planned for their development. 
The strength of our RC is the close collaboration with industry and the third sector. International 
exchange is also increasing both via in-coming and out-coming students.  
 
Several PhD students from our RC were recruited to pharmaceutical and food industry as well as to 
Finnish Medicines Agency during the evaluation period indicating high quality of our doctoral training, 
and our capacity to generate experts in the field of pharmacology and medical nutrition. 
 
Most of the research groups utilize PhD Student Committees in the supervision and follow-up of PhD 
students. PhD students participate actively and regularly in group meetings, department meetings as 
well as the courses organized by the graduate schools.  
 
There is a substantial lack of coherent research career development possibilities (post-doc positions), 
although the tenure track system was very recently started in the University of Helsinki. 
 
 
 Description of how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector).  
Members of the RC form the nucleus of Helsinki Hypertension Centre of Excellence. The Helsinki 
Hypertension Centre of Excellence is part of the European Hypertension Excellence Centre network of 
the European Society of Hypertension (ESH). It was approved by ESH in June 17, 2008, serves the 
Hospital District of Helsinki and Uusimaa, and collaborates nationally with Turku Hypertension Centre 
and Tampere University Hospital. Within the centre, it collaborates with all specialities involved in 
hypertension and hypertension related cardiovascular diseases (diagnosis, prevention, treatment, 
education and research).  
3 SOCIETAL IMPACT OF RESEARCH AND DOCTORAL TRAINING (MAX. 4400 CHARACTERS WITH SPACES) 
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Leading doctors/scientists  Speciality 
•Ilkka Tikkanen*, docent, head   – nephrology 
•Frej Fyhrquist*, professor(emer)  – internal medicine 
•Timo Hiltunen, docent – hypertension genetics, internal medicine 
•Eero Honkanen, docent – nephrology 
•Olli Häppölä, docent – neurology 
•Ilkka Immonen, docent – ophthalmology 
•Hannu Jalanko, professor – pediatrics 
•Risto Kaaja*, professor –hypertension in women/obstetric hypertension 
•Kimmo Kontula*, professor – hypertension genetics, internal medicine 
•Riitta Korpela, professor – nutritional physiology 
•Mauri Lepäntalo, professor – vascular surgery 
•Eero Mervaala, professor – cardiovascular and metabolic pharmacology 
•Markku S. Nieminen*, professor – cardiology 
•Tuula Tikkanen*, docent – internal medicine/general practise 
•Matti Välimäki, professor – endocrinology 
*clinical hypertension specialists of the European Society of Hypertension 
 
Hospital/Research locations: 
• Helsinki University Central Hospital (departments of nephrology, cardiology, endocrinology, vascular 
surgery, neurology, ophthalmology, pediatrics, and obstetrics & gynaecology) 
• Helsinki City Hospital Laakso (outpatient clinics) 
• Biomedicum Helsinki, University of Helsinki  
 
Finnish Hypertension Society 
- Eero Mervaala, current president and board member 
- Ilkka Tikkanen, past president and board member 
- Finnish Hypertension Society has vast societal impact: It is responsible for current care guidelines, 
organizes post-graduate training and education, and public counselling 
 
Finnish Nutrition Society 
- Riitta Korpela, current president and board member 
Prof. Korpela is the chairman of the Finnish Society of Nutrition Science and a Finnish representative in 
the European Joint Programming initiative “ A healthy diet for a healthy life”. 
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The Medical Nutrition Physiology Group leads a Tekes-funded project (Valio, Unilever, DSM, Finnish Red 
Cross, Oriola) and is a participant in the industry-lead Health and Wellness SHOK program. The group is 
partner of the European Science Foundation funded European Network for Gastrointestinal Health 
Research. 
 Ways to strengthen the societal impact of the RC’s research and doctoral training. 
Participation in the TEKES-funded SHOK program.  
 
Increasing visibility by organizing public presentations and open seminars and by writing popular 
articles.  
 
Taking actively part into the actions organized by Helsinki Hypertension Centre of Excellence, Finnish 
Hypertension Society, and Finnish Nutrition Society. 
 
 
 
 Description of the RC’s research collaborations and joint doctoral training activities and how the RC 
has promoted researcher mobility.  
Cardiovascular Pharmacology Group 
National Collaborators (outside CARDIOMED) 
Kari Alitalo, professor, research program of Molecule and Cancer Biology 
Matti J. Tikkanen, professor (UH) 
Matej Oresic, professor (Technical Research Centre of Finland) 
Karl-Heinz Herzig, professor (University of Oulu) 
Ove Eriksson, docent (UH) 
RIsto Lapatto, docent (Helsinki University Hospital) 
Collaboration with pharmaceutical industry: Orion Pharma 
Collaboration with food industry: Valio 
Main International Collaborators 
Profs. Friedrich Luft, Michael Bader, Dominik Muller, Max DelBruck Center for Molecular Medicine 
(MDC), Berlin, Germany 
Jens Titze, MD, PhD, University of Erlangen, Germany 
Ramaroson Andriatsitohaina, MD, PhD, University of Angers, France. 
 
Prof. Mervaala is currently hosting one visiting PhD student from Russia (Alyona Inczhutova, MD, CIMO 
fellowship for 18 months) and one PhD student from Italy (Alice Bradachia, MSc, 6 months). 
 
Regenerative Pharmacology Group 
National collaborators (outside CARDIOMED) 
Finnish Red Cross Blood Service (Senior Medical Officer Matti Korhonen) 
Regea Institute for Regenerative Medicine (Docent Susanna Miettinen) 
4 INTERNATIONAL AND NATIONAL (INCL. INTERSECTORAL) RESEARCH COLLABORATION AND RESEARCHER 
MOBILITY (MAX. 4400 CHARACTERS WITH SPACES) 
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International collaborators 
Osaka University Graduate School of Medicine, Japan (Prof. Yoshiki Sawa) 
Hannover Medical School, Germany (prof. Axel Haverich) 
Slovak Academy of Sciences (DSc Jozef Bizik) 
 
Medical Nutrition Physiology Group  
International collaboration with University of Strasbourg and INRA, Toulouse, France. 
National collaboration with National Institute for Health and Welfare, Hospital District of Helsinki and 
Uusimaa, Finnish Institute of Occupational Health and Institute of Medical Technology, University of 
Tampere. 
Joint doctoral training with INRA France and in 2011 also University of Cork, Ireland. 
One PhD student (Hanne Keränen) is working in INRA France since December 2009. Pauliina Ehlers 
performed one experiment in Strasbourg University. Other short visits have been performed during the 
evaluation time in Strasbourg University and INRA France. 
 
Unit of Cardiovascular Research 
Collaborators (national): 
Ari Harjula, Professor (Helsinki University Hospital) 
Esko Kankuri, Docent (University of Helsinki) 
Markku Kupari, Professor (Helsinki University Hospital) 
Eero Mervaala,  Professor (University of Helsinki) 
Kari Pulkki, Professor (University of Kuopio) 
Ilkka Pörsti, Professor (University of Tampere) 
International collaboration/research mobility: 
European Society of Hypertension Excellence Centre Network: Clinical Hypertension Trials 
Jere Paavola acted as a visiting research fellow at the Yale University School of Medicine, New Haven, 
CT, USA, 10/2008-4/2010 
 
The RC has also promoted researcher mobility via recruitment of PhD students from pharmaceutical and 
food industry. RC has taken a strong responsibility to provide doctoral training in Pharmacology and 
Medical Nutrition for its PhD students. Several previous PhD students of the RC have been recruited in 
pharmaceutical industry, food industry as well as in Finnish Medicines Agency during the evaluation 
period. 
 RC’s strengths and challenges related to research collaboration and researcher mobility, and the 
actions planned for their development. 
The RC has a very wide colloboration network both nationally as well as internationally which enables 
researcher mobility. 
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The European Science Foundation funded European Network for Gastrointestinal Health Research will 
give opportunities and grants to student exchange programs.  An international winter school for PhD 
students in the field of nutrition and inflammation was organized by the RC in 2009 and the second one 
will be organized in 2012. 
 
 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties).  
The RC has adequate and modern laboratory space in the Institute of Biomedicine, Institute of Clinical 
Medicine and Minerva Foundation Institute for Medical Research, and either possess or have access to a 
number of state-of-the-art equipment and technologies (Biomedicum Helsinki Core facility Units). 
Clinical Research is conducted in the Institute of Clinical Medicine / Helsinki University Hospital. Funding 
of novel equipments is based on applications for funding submitted to “infrastructural calls” opened by 
UH, Academy of Finland, or locally by the Institute of Biomedicine. 
 
All principal investigators have a substantial amount of teaching duties in their Institutes. Every PhD 
student also participates to some extent to teaching duties (max. 40 hours per year). 
 RC’s strengths and challenges related to operational conditions, and the actions planned for their 
development. 
The RC has been successful in getting external funding. 
 
RC’s research activities are dependent on competitive external and complementary short-term funding, 
and therefore grant applications demand a significant part of the principal investigator’s time. All 
principal investigators have a substantial amount of teaching duties in their Institutes. 
 
 
 
 Description of the execution and processes of leadership in the RC, how the management-related 
responsibilities and roles are distributed in the RC and how the leadership- and management-related 
processes support high quality research, collaboration between principal investigators and other 
researchers in the RC, the RC’s research focus and strengthening of the RC’s know-how.  
The research carried out in the RC is based on the principle that research groups enjoy independence of 
action. Scientific research in the groups is driven by the principal investigators. Principal investigators 
are also responsible for obtaining external funding for their research and leading their research group 
following their strategic research plans. As all the principal investigators are affiliated either to Institute 
of Biomedicine, Institute of Clinical Medicine or Minerva Foundation Institute for Medical Research, the 
RC receives to some extent technical and administrative support from the Institutes’ budget funding. 
 RC’s strengths and challenges related to leadership and management, and the actions planned for 
developing the processes. 
RC’s research is multidisciplinary and translational, which can be considered as a strength of the RC. 
Members of the RC are young, team leaders innovative, and there is an open dialogue and collaboration 
between different research groups within the RC, as well as with other reseach groups working in the 
same field.  
 
5 OPERATIONAL CONDITIONS (MAX. 4400 CHARACTERS WITH SPACES) 
6 LEADERSHIP AND MANAGEMENT IN THE RESEARCHER COMMUNITY (MAX. 4400 CHARACTERS WITH SPACES) 
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There is a substantial lack of coherent research career development possibilities (i.e. post-doctoral 
positions), although the tenure track system was very recently started in the University of Helsinki. 
 
 
 
 Listing of the RCs external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 
 Academy of Finland (AF) - total amount of funding (in euros) AF has decided to allocate to the RC 
members during 1.1.2005-31.12.2010: 363250 
 
 Finnish Funding Agency for Technology and Innovation (TEKES) - total amount of funding (in euros) 
TEKES has decided to allocate to the RC members during 1.1.2005-31.12.2010: 1341279 
 
 European Union (EU) - total amount of funding (in euros) EU has decided to allocate to the RC members 
during 1.1.2005-31.12.2010:  
 
 European Research Council (ERC) - total amount of funding (in euros) ERC has decided to allocate to the 
RC members during 1.1.2005-31.12.2010:  
 
 International and national foundations – names of international and national foundations which have 
decided to allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their 
funding (in euros).  
- names of the foundations: Sigrid Juselius Foundation, Päivikki ja Sakari Sohlberg Foundation, 
Finnish Foundation for Cardiovascular Research 
- total amount of funding (in euros) from the above-mentioned foundations: 334500 
 
 Other international funding - names of other international funding organizations which have decided to 
allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in 
euros). 
- names of the funding organizations:  
- total amount of funding (in euros) from the above-mentioned funding organizations:  
 
 Other national funding (incl. EVO funding and Ministry of Education and Culture funded doctoral 
programme positions) - names of other national funding organizations which have decided to allocate 
funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in euros). 
- names of the funding organizations: EVO-funding, pharmaceutical industry, food industry, 
University of Kuopio Funds, University of Helsinki Funds 
- total amount of funding (in euros) from the above-mentioned funding organizations: 1754896 
 
 
 
 Description of the RC’s future perspectives in respect to research and doctoral training. 
The mission of the RC is to elucidate novel therapeutic targets and to develop safer and more efficient 
prevention and intervention strategies for cardiovascular disease continuum. 
7 EXTERNAL COMPETITIVE FUNDING OF THE RC 
8 RC’S STRATEGIC ACTION PLAN FOR 2011–2013 (MAX. 4400 CHARACTERS WITH SPACES) 
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Main focus of RC’s research will be a more comprehensive, translational approach to cover the 
‘cardiovascular disease continuum’ from risk factors (including diet and dietary interventions) and 
genetic background to prevention and treatment of cardiac, vascular and renal end organ damage and 
dysfunction. 
 
Aims and tools: 
-further development and strengthening of the existing versatile basic methodology and collaboration 
-utilization and application of novel experimental models (e.g. zebra fish methodology, cell cultures 
including iPS-cells, gene expression and transfection studies) and tools (genomics - 
miRNA/transcriptomics – proteomics – metabolomics),  
-more systematic application of  basic findings and methodology to clinical patient materials and 
questions to improve early diagnostic and prognostic evaluation (application of genomics - 
miRNA/transcriptomics – proteomics – metabolomics) as well as tailored prevention treatment of 
cardiovascular diseases 
-collaboration with University Hospital Clinics 
-utilization of the Helsinki Hypertension Centre of Excellence network (national, international) 
-to initiate a PhD Study seminar common to all members of the RC. Seminars will be given by PhD 
students, researchers participating in the RC, and invited speakers. 
-Principal investigators are encouraged to use more frequently PhD Thesis Committees, and to utilize 
more structural forms to follow the progress of the PhD thesis like in the graduate schools 
-the visibility of the research carried out in RC is increased through high-level publications and active 
participation in scientific meetings. 
-Principal investigators are encouraged to take full use of their national and international contacts to 
attract promising post-doctoral students to our RC. 
 
 
 
All principal investigators have contributed to the compilation of the stage 2 materials by providing 
detailed information on their research activities and doctoral training to the responsible person (Prof. 
Mervaala). All principal investigators have also contributed to the writing of the strategic action plan for 
2011-2013. 
9 SHORT DESCRIPTION OF HOW THE RC MEMBERS HAVE CONTRIBUTED TO THE COMPILATION OF THE STAGE 2 
MATERIALS (MAX. 1100 CHARACTERS WITH SPACES). 
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1 Analysis of publications 
 
- Associated person is one of Eero Mervaala ,  Riitta Anneli Korpela ,  Heikki Vapaatalo , 
 Ari Harjula ,  Ilkka Tikkanen ,  Esko Markus Kankuri ,  Mika 
Laine ,  Piet Matias Finckenberg , Marjut Anneli Louhelainen ,  Agnieszka Biala , 
 Juha Ketonen, Taru Kyllikki Pilvi ,  Erik Vahtola ,  Eveliina Tauriainen , 
 Jin Shi ,  Pauliina Ehlers ,  Päivi Lakkisto ,  Jere Paavola , 
 Antti Markus Siltanen ,  Kristo Nuutila ,  Matti Peura , 
 
Publication year 
Publication type 2005 2006 2007 2008 2009 2010 
Total Count 2005 - 
2010 
A1 Refereed journal article 34 20 33 37 32 31 187 
A2 Review in scientific journal 1  3 1  5 10 
A3 Contribution to book/other compilations (refereed) 1   2 1  4 
A4 Article in conference publication (refereed) 1 2  1 1 1 6 
B1 Unrefereed journal article 3 5 4 1 4 1 18 
C2 Edited book, compilation, conference proceeding or special issue of 
journal 
 1  1  1 3 
D2 Article in professional hand or guide book or in a professional data 
system, or text book material 
 2    1 3 
E1 Popular article, newspaper article 4  1 3   8 
H1 Patents   1 1   2 
 
 
 
CardioMed/Mervaala 
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Biala, A, Martonen, E, Kaheinen, P, Levijoki, J, Finckenberg, P, Merasto, S, Louhelainen, M, Muller, DN, Luft, FC, Mervaala, E  2010, 
'Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure', Hypertension 
Research, vol 33, pp. 1004-1011. 
Biala, A, Tauriainen, E, Siltanen, A, Shi, J, Merasto, S, Louhelainen, M, Martonen, E, Finckenberg, P, Muller, DN, Mervaala, E  2010, 
'Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human 
renin and angiotensinogen genes', Blood Pressure, vol 19, pp. 196-205. 
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Bry, M, Kivelä, R, Holopainen, T, Anisimov, A, Tammela, T, Soronen, J, Silvola, J, Saraste, A, Jeltsch, M, Korpisalo, P, Carmeliet, P, 
Lemström, KB, Shibuya, M, Yla-Herttuala, S, Alhonen, L, Mervaala, E, Andersson, LC, Knuuti, J, Alitalo, K 2010, 'Vascular Endothelial 
Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation',  
Circulation (Baltimore), vol 122, no. 17, pp. 1725-1733. 
Eriksson, M, Lemström, KB, Suojaranta-Ylinen, RT, Martelius, T, Harjula, A, Sipponen, J, Halme, M, Piilonen, A, Salmenkivi, KM, 
Anttila, VA, Hämmäinen , P 2010, 'Control of Early Aspergillus Mortality After Lung Transplantation: Outcome and Risk Factors ', 
Transplantation Proceedings, vol 42, no. 10, pp. 4459-4464. 
Finckenberg, P, Mervaala, E 2010, 'Novel regulators and drug targets of cardiac hypertrophy',  Journal of Hypertension, vol 28, pp. 33-
38. 
Hannila-Handelberg, T, Kontula, KK, Paukku, K, Lehtonen, JY, Virtamo, J, Tikkanen, I, Hiltunen, TP 2010, 'Common genetic variations 
of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential 
hypertension', Journal of Hypertension, vol 28, no. 4, pp. 771-779. 
Hatakka, K, Piirainen, L, Pohjavuori, S, Poussa, T, Savilahti, E, Korpela, R 2010, 'Factors associated with acute respiratory illness in 
day care children', Scandinavian Journal of Infectious Diseases, vol 42, pp. 704-711. 
Holma, R, Hongisto, S, Saxelin, M, Korpela, R 2010, 'Constipation Is Relieved More by Rye Bread Than Wheat Bread or Laxatives 
without Increased Adverse Gastrointestinal Effects', Journal of Nutrition, vol 140, pp. 534-541. 
Jauhiainen, T, Pilvi, TK, Cheng, ZJ, kautiainen, H, muller, D, Vapaatalo, H, Korpela, RA, Mervaala, E 2010, 'Milk products containing 
bioactive tripeptides have an antihypertensive effect in double transgenic rats (dTGR)', Journal of Nutrition and Metabolism. 
Jauhiainen, T, Ronnback, M, Vapaatalo, H, Wuolle, K, Kautiainen, H, Groop, P, Korpela, R 2010, 'Long-term intervention with 
Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects',  European Journal of Clinical Nutrition, 
vol 64, pp. 424-431. 
Jokinen , JJ, Hämmäinen , P, Lemström, KB, Lommi, J, Sipponen, J, Harjula, ALJ 2010, 'Association between gastrointestinal 
symptoms and health-related quality of life after heart transplantation', Journal of Heart and Lung Transplantation, vol 29, no. 12, pp. 
1388-1394. 
Jäkälä, P, Turpeinen, A, Rajakari, K, Korpela, RA, Vapaatalo, H  2010, 'Biological effects of casein-derived tripeptide powders are not 
affected by fermentation process', International Dairy Journal, vol 20, no. 5, pp. 366-370. 
Ketonen, J, Pilvi, T, Mervaala, E 2010, 'Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide 
production in C57Bl/6 mice', Heart and Vessels, vol 25, pp. 254-262. 
Ketonen, J, Shi, J, Martonen, E, Mervaala, E 2010, 'Periadventitial Adipose Tissue Promotes Endothelial Dysfunction via Oxidative 
Stress in Diet-Induced Obese C57BI/6 Mice', Circulation Journal, vol 74, no. 7, pp. 1479-1487. 
Kitabayashi, K, Siltanen, A, Patila, T, Mahar, MAA, Tikkanen, I, Koponen, J, Ono, M, Sawa, Y, Kankuri, E, Harjula, A 2010, 'Bcl-2 
Expression Enhances Myoblast Sheet Transplantation Therapy for Acute Myocardial Infarction', Cell Transplantation, vol 19, no. 5, pp. 
573-588. 
Korpela, RA, von Wright, A, Räty, K, Holma, RM, Tuure, T, Mykkänen, H 2010, 'The effect of rye bread and Lactobacillus GG fermented 
whey drink on fecal and urinary mutagenicity and fecal enzyme activities',  International Journal of Probiotics & Prebiotics, vol 2010 / 
5, no. 3, pp. 125-32. 
Kukkonen, K, Kuitunen, M, Haahtela, T, Korpela, R, Poussa, T, Savilahti, E 2010, 'High intestinal IgA associates with reduced risk of 
IgE-associated allergic diseases', Pediatric Allergy and Immunology, vol 21, no. 1, pp. 67-73. 
Lakkisto, P, Kyto, V, Forsten, H, Siren, J, Segersvard, H, Voipio-Pulkki, L, Laine , M, Pulkki, K, Tikkanen, I 2010, 'Heme oxygenase-1 
and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1 alpha, SDF-1 alpha 
and VEGF-B', European Journal of Pharmacology, vol 635, pp. 156-164. 
Lehtinen, R, Jauhiainen, T, Kankuri, E, Lindstedt, K, Kovanen, PT, Kerojoki, O, Korpela, R, Vapaatalo, H  2010, 'Effects of milk casein-
derived tripeptides Ile-Pro-Pro, Val-Pro-Pro, and Leu-Pro-Pro on enzymes processing vaso active precursors in vitro',  Arzneimittel-
Forschung, vol 60, pp. 182-185. 
Louhelainen, M, Merasto, S, Finckenberg, P, Vahtola, E, Kaheinen, P, Levijoki, J, Mervaala, E 2010, 'Effects of the calcium sensitizer 
OR-1896, a metabolite of levosimendan, on post-infarct heart failure and cardiac remodelling in diabetic Goto-Kakizaki rats',  British 
Journal of Pharmacology, vol 160, pp. 142-152. 
Lyra, A, Krogius-Kurikka, L, Nikkila, J, Malinen, E, Kajander, K, Kurikka, K, Korpela, RA, Palva, A 2010, 'Effect of a multispecies 
probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes', BMC Gastroenterology, vol 10, 
no. art. 110. 
Peura, M, Siltanen, A, Saarinen, I, Soots, A, Bizik, J, Vuola, J, Harjula, A, Kankuri, E 2010, 'Paracrine factors from fibroblast aggregates 
in a fibrin-matrix carrier enhance keratinocyte viability and migration', Journal of Biomedical Materials Research. Part A, vol 95A, no. 
2, pp. 658-664. 
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Pohjavuori, S, Ahola, A, Yli-Knuuttila, H, Piirainen, L, Poussa, T, Meurman, J, Korpela, RA 2010, 'Effect of consumption of Lactobacillus 
rhamnosus GG and calcium, in carrot-pineapple juice on dental caries risk in children', International Journal of Probiotics & 
Prebiotics, vol 5, no. 4, pp. 221-228. 
Saukkonen, K, Lakkisto, P, Kaunisto, MA, Varpula, M, Voipio-Pulkki, L, Varpula, T, Pettila, V, Pulkki, K 2010, 'HEME OXYGENASE 1 
POLYMORPHISMS AND PLASMA CONCENTRATIONS IN CRITICALLY ILL PATIENTS', Shock (Philadelphia), vol 34, no. 6, pp. 558-
564. 
Saxelin, M, Tynkkynen, S, Salusjärvi, T, Kajander, K, Myllyluoma, E, Mattila-Sandholm, T, Korpela, RA 2010, 'Developing a multispecies 
probiotic combination', International Journal of Probiotics & Prebiotics, vol 5, no. 4, pp. 169-182. 
Saxelin, M, Lassig, A, Karjalainen, H, Tynkkynen, S, Surakka, A, Vapaatalo, H, Jarvenpaa, S, Korpela, R, Mutanen, M, Hatakka, K  
2010, 'Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese', International 
Journal of Food Microbiology, vol 144, no. 2, pp. 293-300. 
Syvaranta, S, Helske, S, Laine , M, Lappalainen, J, Kupari, M, Mayranpaa, MI, Lindstedt, KA, Kovanen, PT  2010, 'Vascular Endothelial 
Growth Factor-Secreting Mast Cells and Myofibroblasts A Novel Self-Perpetuating Angiogenic Pathway in Aortic Valve Stenosis',  
Arteriosclerosis, Thrombosis, and Vascular Biology, vol 30, pp. 1220-U329. 
Vaajanen, A, Lakkisto, P, Virtanen, I, Kankuri, E, Oksala, O, Vapaatalo, H, Tikkanen, I 2010, 'Angiotensin receptors in the eyes of 
arterial hypertensive rats', Acta Ophthalmologica, vol 88, no. 4, pp. 431-438. 
Vahtola, E, Louhelainen, M, Forsten, H, Merasto, S, Raivio, J, Kaheinen, P, Kyto, V, Tikkanen, I, Levijoki, J, Mervaala, E  2010, 'Sirtuin1-
p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat',  Cardiovascular 
Diabetology, vol 9. 
A2 Review in scientific journal 
2005 
Korpela, R, Saxelin, M 2005, 'Functional dairy products - the Nordic perspective', Australian Journal of Dairy Technology, vol 60, pp. 
170-172. 
2007 
Back, J, Kankuri, E, Ikonen, T, Pätilä, T, Sinisalo, J, Laine, M, Vapaatalo, H, Koponen, J, Hukkanen, M, Ylä-Herttuala, S, Alitalo, R, 
Kupari, M, Harjula, A 2007, 'Solusiirrot sydämen vajaatoiminnan hoidossa: [katsaus]', Duodecim, vol 123, no. 4, pp. 398-405. 
Jauhiainen, T, Korpela, R 2007, 'Milk peptides and blood pressure', Journal of Nutrition, vol 137, pp. 825S-829S. 
Moreira, A, Kekkonen, R, Delgado, L, Fonseca, J, Korpela, R, Haahtela, T 2007, 'Nutritional modulation of exercise-induced 
immunodepression in athletes: a systematic review and meta-analysis', European Journal of Clinical Nutrition, vol 61, pp. 443-460. 
2008 
Jokinen, JJ, Kukkonen, S, Hämmäinen, P, Lommi, J, Kupari, M, Harjula, A, Sipponen, J, Lemström, KB  2008, 'Aikuisten sydämensiirrot 
Suomessa: onko määrää syytä lisätä? : katsaus', Duodecim, vol 124, pp. 1953-1961. 
2010 
Jula, A, Kantola, I, Lehto, S, Mervaala, E, Metsärinne, K, Pörsti, I, Strandberg, T, Tikkanen, I, Tikkanen, T, Kukkonen-Harjula, K 2010, 
'Kohonnut verenpaine: Käypä hoito -suosituksen päivitystiivistelmä', Duodecim, vol 126, pp. 673-674. 
Jäkälä, P, Vapaatalo, H 2010, 'Antihypertensive peptides from milk proteins', Pharmaceuticals, no. 3, pp. 251-272. 
Peuhkuri, K, Vapaatalo, H, Korpela, R 2010, 'Even low-grade inflammation impacts on small intestinal function',  World Journal of 
Gastroenterology, vol 16, no. 9, pp. 1057-1062. 
Tikkanen, I 2010, 'Minkä valitsen ensimmäiseksi verenpainelääkkeeksi?', Duodecim, vol 126, pp. 891-896. 
Vapaatalo, H, Kotikoski, H, Oksala, O 2010, 'Role of nitric oxide in the regulation of intraocular pressure: a possibility for glaucoma 
treatment', Expert review of ophthalmology., vol 5, no. 6, pp. 751-758. 
A3 Contribution to book/other compilations (refereed) 
2005 
Pilvi, T, Jauhiainen, T, Cheng, ZJ, Mervaala, E, Vapaatalo, H, Korpela, R 2005, 'Cardiovascular effects of lupin protein in two 
hypertensive animal models', Optimised processes for preparing healthy and added value food ingredients from lupin kernels, 
the European protein-rich grain legume, Aracne, Roma, pp. 159-168. 
2008 
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Harjula, A 2008, 'Kirurgian erikoislääkärikoulutus', Huippuosaajien yhteisö. [toimituskunta: Reijo Haapiainen ... et al.] ; [kuvat: 
Jukka Alstela ... et al.]., HYKS, operatiivinen tulosyksikkö, [Helsinki], pp. 264-268. 
Tikkanen, I, Tikkanen, T 2008, 'Sekundaariset hypertensiot', in /PJHMK;TJA.[A (ed.), Kardiologia, Duodecim, Helsinki, pp. 1062-
1070. 
2009 
Saxelin, M, Kajander, K, Korpela, RA 2009, 'LGG Extra, A multispecies Probiotic Combination: LGG Extra, A multispecies Probiotic 
Combination.', handbook of Probiotics and Prebiotics, 2nd edn, Hoboken. 
A4 Article in conference publication (refereed) 
2005 
Helske, S, Aalto, S, Kupari, M, Lappalainen, J, Laine, M, Lommi, J, Kovanen, PT, Lindstedt, KA 2005, A role for mast cell-derived 
cathepsin G in the adverse remodelling of stenotic aortic valves,, European Heart Journal 26 OXFORD UNIVERSITY PRESS. 
2006 
Helske, S, Laine, M, Kupari, M, Lommi, J, Tikkanen, I, Werkkala, K, Lindstedt, K, Kovanen, P 2006, Increased expression of profibrotic 
neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves,, Circulation Research 114 LIPPINCOTT WILLIAMS & 
WILKINS. 
Ljungberg, M, Korpela, R, Ilonen, J, Ludvigsson, J, Vaapala, O 2006, 'Probiotics for the prevention of beta cell autoimmunity in children 
at genetic risk of type 1 diabetes- the PRODIA study', in IMMUNOLOGY OF DIABETES IV : PROGRESS IN OUR UNDERSTANDING , 
pp. 360-364 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES , vol. 1079. 
2008 
Mäenpää, J, Kotikoski, H, Aine, E, Alajuuma, P, Oksala, O, Vapaatalo, H 2008, 'Nitric oxide (NO) in the regulation of intraocular 
pressure', in Proceedings of the 7th international symposium on ocular pharmacology &amp; therapeutics (ISOPT), pp. 61-64. 
2009 
Lakkisto, P, Siren, J, Immonen, K, Forsten, H, Kyto, V, Segersvard, H, Voipio-Pulkki, L, Laine, M, Pulkki, K, Tikkanen, I  2009, Carbon 
Monoxide Promotes Neovascularization After Myocardial Infarction by Modulating the Expression of Angiogenic Cytokines and Growth 
Factors,, Circulation Research 120 LIPPINCOTT WILLIAMS & WILKINS. 
2010 
Mervaala, E, Biala, A, Merasto, S, Lempiainen, J, Mattila, I, Martonen, EE, Eriksson, O, Louhelainen, M, Finckenberg, P, Kaheinen, P, 
Muller, DN, Luft, FC, Lapatto, R, Oresic, M 2010, Metabolomics in Angiotensin II-Induced Cardiac Hypertrophy,, Paper presented at 
63rd Annual Fall Conference and Scientific Sessions of the American-Heart-Association-Council-for-High-Blood-Pressure-
Research, Chicago, IL, SEP 23-26, 2009. Hypertension 55 2 LIPPINCOTT WILLIAMS & WILKINS. 
B1 Unrefereed journal article 
2005 
Tikkanen, I 2005, 'Onko uusi verenpainelääke hintansa arvoinen?: [pääkirjoitus]',  Suomen lääkärilehti , vol 60, no. 43, pp. 4355. 
Vapaatalo, H 2005, 'Januskasvoinen ASA: tulevaisuudenkin lääke [katsausartikkeli]', Suomen lääkärilehti , vol 60, no. 9, pp. 1027-
1031. 
Vapaatalo, H, Korpela, R, Jauhiainen, T 2005, 'Letter to the editor: response to Dr. Mizushima', American Journal of Hypertension, 
vol 18, pp. 1015. 
2006 
Kukkonen, K, Savilahti, E, Haahtela, T, Juntunen-Backman, K, Korpela, R, Poussa, T, Tuure, T, Kuitunen, M 2006, 'Pre- ja probiootit 
ehkäisevät atooppisen ekseeman puhkeamista: [referaatti J Allergy Clin Immunol -lehden artikkelista]',  Duodecim, vol 122, no. 24, pp. 
2959-2960. 
Kälviäinen, R, Autti-Rämö, I, Eriksson, K, Häppölä, O, Keränen, T, Kuoppala, J, Kurola, J, Kuusela, A, Mervaala, E, Salmi, T, Tallgren, 
M 2006, 'Pitkittynyt epileptinen kohtaus: [Käypä hoito -suosituksen tiivistelmä]', Duodecim, vol 122, pp. 473-475. 
Mervaala, E 2006, 'Aspiriiniresistenssi', TABU : lääkeinformaatiota Lääkelaitokselta, vol 14 , no. 6, pp. 9-10. 
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Paajanen, L, Korpela, R, Tuure, T, Honkanen, J, Järvelä, I, Ilonen, J, Knip, M, Vaarala, O, Kokkonen, J 2006, 'Lehmänmaito ei ole 
syynä useimpiin puolustusvasteen välittämiin ruoansulatuskanavan oireisiin - näyttö väestötutkimuksesta: [referaatti Am j clin nutr -
lehden artikkelista]', Duodecim, vol 122, pp. 263-264. 
Tikkanen, I 2006, 'Pitäisikö prehypertensiota hoitaa?: [lääketieteellinen pääkirjoitus]',  Suomen lääkärilehti , vol 61, pp. 4811. 
2007 
Harjula, A, Hämmäinen, P, Vento, A 2007, 'Modern surgical techniques of the failing heart: [editorial]', Scandinavian Journal of 
Surgery, vol 96, no. 2, pp. 94-95. 
Järvinen, M, Höckerstedt, K, Alhava, E, Juvonen, T, Puolakkainen, P, Aarnio, P, Kivilaakso, E, Eskelinen, M, Lepäntalo, M, Rintala, R, 
Kröger, H, Jalovaara, P, Ruutu, M, Kiviranta, I, Tammela, T, Tarkka, M, Aro, H, Serlo, W, Mäkelä, J, Harjula, A 2007, 'Kirurgian 
professorit: selvityshenkilöiltä varsin radikaaleja ehdotuksia erikoislääkärikoulutuksesta', Suomen lääkärilehti , vol vsk 62, no. 41, pp. 
3777-3779. 
Kajander, K, Latti, M, Hatakka, K, Korpela, R 2007, 'An electronic diary versus a paper diary in measuring gastrointestinal symptoms', 
Digestive and Liver Disease, vol 39, pp. 288-289. 
Vapaatalo, H, Viinikka, L 2007, 'Suomalainen sauna: terveytemme turva vai turma? [pääkirjoitus]', Duodecim, vol 123, pp. 1538-1539. 
2008 
Kajander, K, Vapaatalo, H, Korpela, R 2008, 'Probiotics and the irritable bowel syndrome: authors' reply [letter]',  Alimentary 
Pharmacology & Therapeutics, vol 27, pp. 617-618. 
2009 
Eräranta, A, Lakkisto, P, Tikkanen, I, Mustonen, J, Pörsti, I 2009, 'Paricalcitol and renin-angiotensin components in remnant kidneys: 
[letter to the editor]', Kidney International, vol 75, no. 3, pp. 339-340. 
Harjula, A, Vento, A, Hämmäinen, P, Pätilä, T, Kankuri, E 2009, 'Onko xenosta ja kantasoluista haastajaksi?', Sydänääni : Suomen 
kardiologisen seuran lehti., vol 20, no. 3A, pp. 50-56. 
Hämmäinen, P, Jokinen, JJ, Yesil, C, Hellstedt, M, Harjula, A 2009, 'Millainen elämänlaatu?', Sydänääni : Suomen kardiologisen 
seuran lehti., vol 20, no. 3A, pp. 41-45. 
Vaajanen, A, Vapaatalo, H 2009, 'Sääteleekö reniini-angiotensiinijärjestelmä silmänkin painetta?: [pääkirjoitus]', Duodecim, vol 125, no. 
18, pp. 1931-1933. 
2010 
Vapaatalo, H, Mervaala, E 2010, 'Endoteelin typpioksidin löytäjä on poissa: mihin havainto on johtanut kolmessa vuosikymmenessä?', 
Duodecim, vol 126, no. 5, pp. 577-578. 
C2 Edited book, compilation, conference proceeding or special issue of journal 
2006 
Aarnio, P, Airaksinen, J, Armstrong, E, Harjula, A, Juntunen, J, Juvonen, T, Lassila, R, Naukkarinen, M, Roine, RO, Syvänne, M, 
Taajamaa, B, Uurto, I, Ylitalo, A, Harjula, ALJ (eds) 2006, Angiologia, Recallmed, [Klaukkala]. 
2008 
Harjula, A, Aarnio, P 2008, Käytännön lääkärin täsmähoidon ABC: diagnoosista terapiaan, Recallmed, Klaukkala. 
2010 
Vapaatalo, H, Vaajanen, A, Alajuuma, P, Oksala, O 2010, Does the renin-angiotensin system (RAS) regulate also intraocular pressure, 
The Open Proceedings Journal, 2nd International Conference on Drug Discovery and Therapy. 
D2 Article in professional hand or guide book or in a professional data system, or text book 
material 
2006 
Jula, A, Kantola, I, Koivisto, P, Luostarinen, E, Mervaala, E, Niskanen, L, Olkinuora, J, Pyörälä, K, Ruskoaho, H, Tikkanen, I, 
Tuomilehto, J, Fyhrquist, F, Keinänen-Kiukaanniemi, S, Kukkonen-Harjula, K, Majahalme, S, Nieminen, M, Nissinen, A, Pentikäinen, P, 
Romo, M, Takala, J, Tikkanen, T, Turjanmaa, V 2006, 'Kohonnut verenpaine: Käypä hoito -suosituksen tiivistelmä', Kohonnut 
verenpaine. Käypä hoito -suosituksen tiivistelmä., vol. 122. 
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Välimäki, M, Alhava, E, Aro, H, Irjala, K, Heinonen, A, Hirvonen, E, Jousilahti, P, Kröger, H, Lamberg-Allardt, C, Malmivaara, A, Mattila, 
K, Mervaala, E, Möttönen, T, Salmela, P, Salmi, J, Salovaara, K, Savolainen, A, Suominen, H, Tuppurainen, M, Viikari, J 2006, 
'Osteoporoosi: päivitetty Käypä hoito -suositus', Osteoporoosi. päivitetty Käypä hoito -suositus., pp. 1-24. 
2010 
Kantonen, IK, Kemppainen, E, Tikkanen, I 2010, 'Vatsa-aortan suurten sivuhaarojen sairaudet', in PJ Roberts, P Aarnio, K Höckerstedt, 
A Leppäniemi (eds), Kirurgia, 2. uud. p. edn, Kustannus Oy Duodecim, Helsinki, pp. 722-728. 
E1 Popular article, newspaper article 
2005 
Ahtee, L, Airaksinen, M, Korpi, E, Neuvonen, PJ, Paakkari, I, Seppälä, T, Vapaatalo, H 2005, 'In memoriam: Mauri J. Mattila 
16.12.1930-8.11.2005', Suomen lääkärilehti , vol 60, pp. 5182. 
Solatunturi, E, Vapaatalo, H 2005, 'In memoriam: Matti K. Paasonen 10.12.1925-7.4.2005', Suomen lääkärilehti , vol 60, no. 22, pp. 
2520. 
Vapaatalo, H, Solatunturi, E 2005, 'Matti K. Paasonen *10.12.1925 +7.4.2005: in memoriam', Suomalainen Tiedeakatemia. 
Vuosikirja, pp. 133-135. 
Vapaatalo, H 2005, 'Pieni vaiva - hyvä mieli [kirja-arvostelu]', Suomen lääkärilehti , vol 60, no. 47, pp. 4902. 
2007 
Vapaatalo, H 2007, 'Bioaktiiviset peptidit ja verenpaine', Nutrifocus, no. 1, pp. 15-17. 
2008 
Mervaala, E 2008, 'SIRT1-aktivaatio: uusi keino metabolisen oireyhtymän ennaltaehkäisyyn?', Nutrifocus : ajankohtaisia 
ravitsemustutkimuksia, no. 2, pp. 12-13. 
Pilvi, T 2008, 'Maitoproteiinit ja kalsium: metabolinen oireyhtymä hallintaan ravinnolla',  Nutrifocus : ajankohtaisia 
ravitsemustutkimuksia, no. 2, pp. 14-15. 
Ylitalo, P, Vapaatalo, H 2008, 'Poimintoja Suomen farmakologian historiasta: vuorossa Tampere', Transmitteri : Suomen 
farmakologiyhdistyksen jäsenlehti, vol 25, no. 85, pp. 8-11. 
H1 Patents 
2007 
Harjula, A, Kankuri, EM, Bizik, J 2007, Method and device for treating or selecting cells, WO/2007/113387. 
2008 
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